tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ACHL Stock Latest News

Piper downgardes Achilles Therapeutics, says ‘step-function’ change needed
The FlyPiper downgardes Achilles Therapeutics, says ‘step-function’ change needed
16d ago
ACHL
Achilles Therapeutics price target lowered to $6 from $11 at Chardan
PremiumThe Fly
Achilles Therapeutics price target lowered to $6 from $11 at Chardan
16d ago
ACHL
Achilles Therapeutics downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Achilles Therapeutics downgraded to Neutral from Overweight at Piper Sandler
16d ago
ACHL
Achilles Therapeutics reports Q4 EPS (46c) vs. (61c) last year
PremiumThe Fly
Achilles Therapeutics reports Q4 EPS (46c) vs. (61c) last year
16d ago
ACHL
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
PremiumPress Releases
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
16d ago
ACHL
Achilles Therapeutics provides update on Phase I/IIa NSCLC results
PremiumThe FlyAchilles Therapeutics provides update on Phase I/IIa NSCLC results
16d ago
ACHL
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
PremiumPress Releases
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
16d ago
ACHL
Achilles Therapeutics Plc (ACHL) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Achilles Therapeutics Plc (ACHL) Q4 Earnings Cheat Sheet
2M ago
ACHL
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
PremiumPress Releases
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
2M ago
ACHL
Achilles announces publication on neoantigen immunogenicity prediction
PremiumThe Fly
Achilles announces publication on neoantigen immunogenicity prediction
4M ago
ACHL
Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
PremiumPress Releases
Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
4M ago
ACHL
Achilles Therapeutics just downgraded at BofA, here’s why
PremiumThe Fly
Achilles Therapeutics just downgraded at BofA, here’s why
4M ago
ACHL
Achilles Therapeutics reports Q3 EPS (42c), consensus (40c)
PremiumThe FlyAchilles Therapeutics reports Q3 EPS (42c), consensus (40c)
5M ago
ACHL
Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
PremiumPress Releases
Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
5M ago
ACHL
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
PremiumPress Releases
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
7M ago
ACHL
Achilles Therapeutics reports Q2 EPS (42c), consensus (42c)
PremiumThe Fly
Achilles Therapeutics reports Q2 EPS (42c), consensus (42c)
9M ago
ACHL
Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
PremiumPress Releases
Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
9M ago
ACHL
Achilles Therapeutics to Present at Upcoming Conferences
PremiumPress Releases
Achilles Therapeutics to Present at Upcoming Conferences
10M ago
ACHL
Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
PremiumPress Releases
Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
12M ago
ACHL
Achilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell Antigens
PremiumPress ReleasesAchilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell Antigens
12M ago
ACHL
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
PremiumPress Releases
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
12M ago
ACHL
Achilles Therapeutics receives Nasdaq deficiency notice
PremiumThe Fly
Achilles Therapeutics receives Nasdaq deficiency notice
12M ago
ACHL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >